O IMPACTO DA MICROBIOTA INTESTINAL NOS PRIMEIROS 1000 DIAS: REPERCUSSÕES SISTÊMICAS E PERSPECTIVAS TERAPÊUTICAS NA FARMACOBIÔMICA PEDIÁTRICA: UMA REVISÃO SISTEMÁTICA
LUMEN ET VIRTUS · 21.07.2026 · 17 (62) · e13833
DOI: 10.56238/levv17n62-036 ↗Kurz gefasst
Fachartikel in der Zeitschrift LUMEN ET VIRTUS, online erschienen am 21.07.2026. Verfasst von Gabriel Sousa Rodrigues und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To analyze the scientific literature on the critical role of the gut microbiome in the first 1000 days of life, evaluating the systemic repercussions of early dysbiosis and the efficacy of therapeutic modulation strategies in the pediatric population. Methodology: A systematic review guided by the structured question (PVO): "What are the long-term systemic consequences of early intestinal dysbiosis, and what is the impact of therapeutic modulation in the pediatric population?". Searches were conducted in PubMed Central (PMC) and ScienceDirect databases using the descriptors: Intestinal Microbiome, Dysbiosis, Children, and Therapeutics. Out of 428 initially identified studies, rigorous inclusion and exclusion criteria were applied, resulting in the selection of 30 high-impact articles (2019-2024) for the qualitative synthesis.
Results
Consolidated evidence demonstrates that initial microbial colonization acts on the host's epigenetic programming. Dysbiosis, frequently induced by early empirical antibiotic therapy, profoundly affects three main pathways: the gut-immune axis (predisposing to atopy and autoimmunity), the gut-metabolic axis (associated with insulin resistance and childhood obesity), and the gut-brain axis (correlated with neurodevelopmental disorders, such as autism). Modulation strategies, including specific probiotics (strains), prebiotics (HMOs), and Fecal Microbiota Transplantation (FMT), demonstrate remarkable efficacy in restoring eubiosis, although they require strict biosafety monitoring in intensive care settings.
Conclusion
The interaction between the gut microbiota and systemic development highlights the intestine's role as a "master organ" of pediatric homeostasis. Prophylactic interventions, such as promoting breastfeeding and the judicious use of antimicrobials, must be prioritized in public health protocols. The modern management of dysbiosis is advancing toward precision pharmacobiomics, demanding targeted, safe, and individualized microbiological therapies.
Zitieren
APA
Rodrigues, G. S., Machado, A. L. T. D. C., Costa, M. C. D. S. P. D., Kairala, R. O. M., & Tristão, M. E. A. M. D. A. (2026). O IMPACTO DA MICROBIOTA INTESTINAL NOS PRIMEIROS 1000 DIAS: REPERCUSSÕES SISTÊMICAS E PERSPECTIVAS TERAPÊUTICAS NA FARMACOBIÔMICA PEDIÁTRICA: UMA REVISÃO SISTEMÁTICA. LUMEN ET VIRTUS, 17(62), e13833. https://doi.org/10.56238/levv17n62-036
Vancouver
Rodrigues GS, Machado ALTDC, Costa MCDSPD, Kairala ROM, Tristão MEAMDA. O IMPACTO DA MICROBIOTA INTESTINAL NOS PRIMEIROS 1000 DIAS: REPERCUSSÕES SISTÊMICAS E PERSPECTIVAS TERAPÊUTICAS NA FARMACOBIÔMICA PEDIÁTRICA: UMA REVISÃO SISTEMÁTICA. LUMEN ET VIRTUS. 2026;17(62):e13833. doi:10.56238/levv17n62-036
BibTeX
@article{Rodrigues2026,
author = {Rodrigues, Gabriel Sousa and Machado, Ana Luiza Teles da Costa and Costa, Maísa Carvalho de Santana Prudêncio da and Kairala, Rafaella Oliveira Mellem and Tristão, Maria Eugênia Alves Martins de Araújo},
title = {O IMPACTO DA MICROBIOTA INTESTINAL NOS PRIMEIROS 1000 DIAS: REPERCUSSÕES SISTÊMICAS E PERSPECTIVAS TERAPÊUTICAS NA FARMACOBIÔMICA PEDIÁTRICA: UMA REVISÃO SISTEMÁTICA},
journal = {LUMEN ET VIRTUS},
year = {2026},
volume = {17},
number = {62},
pages = {e13833},
doi = {10.56238/levv17n62-036}
}
EUVIMED